Coralville, Iowa-based Kempharm Inc. has won FDA approval for Apadaz for the short-term management of acute pain. The drug is an immediate-release combination of Kempharm's hydrocodone prodrug, benzhydrocodone, and acetaminophen (APAP). It's the first prodrug of hydrocodone/acetaminophen to be approved by FDA.